FDA just issued its 2018 Strategic Policy Roadmap https://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/UCM592001.pdf FDA continues to deceptively portray its 2016 vapor Deeming Ban as a regulation to reduce cigarette smoking and encourage new technology and product innovation for vapor products. There is no mention that the Deeming Rule banned sales of ALL new vapor products on 8/8/2016, bans sales of >99.999% of the 3 million FDA registered vapor products on 8/8/2022, and banned vapor companies from truthfully informing smokers that vapor products are less harmful than cigarettes. Nor is there any mention that FDA's forthcoming vapor product standards could ban most 8/8/2016 vapor products before 2022. As FDA moves forward with its comprehensive new approach, the Agency must also take a fresh look at products that can deliver satisfying levels of nicotine to adults who want access to it without burning tobacco. With appropriate product regulation, new technology, and product innovation – including new medicinal nicotine products and electronic nicotine delivery systems (ENDS) – could present an opportunity for more smokers to quit combustible tobacco and stay quit. Our plan takes new steps to foster innovation in nicotine delivery, where such innovation could truly make a positive public health impact. It also makes sure that FDA has the foundational regulations to put products such as electronic cigarettes through an appropriate series of regulatory checkpoints. Perhaps even worse for smokers and public health, FDA continues to deceptively promote its cigarette prohibition policy as a regulation to make cigarettes non addictive. No mention of the enormous black markets for untaxed (and perhaps lower cost) cigarettes it would create (very similar to alcohol prohibition nearly a century ago, which restricted the amount alcohol to no more than 1% in beer, wine and other drinks).